BFC Planning’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.62K Buy
9
+7
+350% +$2.32K ﹤0.01% 2927
2026
Q2
$670 Buy
+2
New +$633 ﹤0.01% 3214
2025
Q4
– Sell
-6
Closed -$318 – 3306
2025
Q3
$318 Buy
+6
New +$291 ﹤0.01% 2792

Other funds holding PRAX

BFC Planning's PRAX Position: Q3 2026 in Review

BFC Planning increased its Praxis Precision Medicines (PRAX) stake by 350% in Q3 2026, buying an estimated $2.32K and bringing the position to 9 shares worth $2.62K. The position accounts for ﹤0.01% of the portfolio, ranked #2927.

BFC Planning first reported a position in PRAX in Q3 2025 and has held it in 3 quarters since. 237 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • BFC Planning held 9 shares of Praxis Precision Medicines worth $2.62K as of Q3 2026.
  • BFC Planning bought 7 Praxis Precision Medicines shares in Q3 2026, an estimated $2.32K.
  • Praxis Precision Medicines made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2927 holding.
  • BFC Planning first reported a position in Praxis Precision Medicines in Q3 2025 and has held it in 3 quarters since.
  • 237 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.